{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:54:36Z","timestamp":1772160876309,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":522,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Diabetes"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1111\/pedi.12138","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T07:40:10Z","timestamp":1395992410000},"page":"104-108","source":"Crossref","is-referenced-by-count":12,"title":["Medication-induced diabetes during induction treatment for ALL, an early marker for future metabolic risk?"],"prefix":"10.1155","volume":"16","author":[{"given":"Yonatan","family":"Yeshayahu","sequence":"first","affiliation":[{"name":"Division of Endocrinology; Safra Children's Hospital; Ramat Gan Israel"},{"name":"Department of Pediatrics; Tel-Aviv University; Tel-Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dror","family":"Koltin","sequence":"additional","affiliation":[{"name":"Division of Endocrinology; The Hospital for Sick Children; Toronto ON Canada"},{"name":"Department of Pediatrics; University of Toronto; Toronto ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Division of Endocrinology; The Hospital for Sick Children; Toronto ON Canada"},{"name":"Department of Pediatrics; University of Toronto; Toronto ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Nathan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; University of Toronto; Toronto ON Canada"},{"name":"Division of Haematology Oncology; The Hospital for Sick Children; Toronto ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Urbach","sequence":"additional","affiliation":[{"name":"Division of Endocrinology; The Hospital for Sick Children; Toronto ON Canada"},{"name":"Department of Pediatrics; University of Toronto; Toronto ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,3,28]]},"reference":[{"key":"10.1111\/pedi.12138-BIB0001|pedi12138-cit-0001","volume-title":"SEER Cancer Statistics Review, 1975-2008","author":"Howlader","year":"2011"},{"key":"10.1111\/pedi.12138-BIB0002|pedi12138-cit-0002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(81)80955-9","article-title":"Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone","volume":"99","author":"Pui","year":"1981","journal-title":"J Pediatr"},{"key":"10.1111\/pedi.12138-BIB0003|pedi12138-cit-0003","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/pbc.21980","article-title":"Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia","volume":"52","author":"Lowas","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/pedi.12138-BIB0004|pedi12138-cit-0004","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/pbc.20320","article-title":"Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia","volume":"45","author":"Baillargeon","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/pedi.12138-BIB0005|pedi12138-cit-0005","doi-asserted-by":"crossref","DOI":"10.1007\/s00520-011-1307-5","article-title":"Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics","volume":"20","author":"Koltin","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1111\/pedi.12138-BIB0006|pedi12138-cit-0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/leu.2008.289","article-title":"Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia","volume":"23","author":"Roberson","year":"2009","journal-title":"Leukemia"},{"key":"10.1111\/pedi.12138-BIB0007|pedi12138-cit-0007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/pbc.21624","article-title":"Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia","volume":"51","author":"Sonabend","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/pedi.12138-BIB0008|pedi12138-cit-0008","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpeds.2009.01.072","article-title":"Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia","volume":"155","author":"Sonabend","year":"2009","journal-title":"J Pediatr"},{"key":"10.1111\/pedi.12138-BIB0009|pedi12138-cit-0009","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1200\/JCO.2010.32.0325","article-title":"Improved prognosis for older adolescents with acute lymphoblastic leukemia","volume":"29","author":"Pui","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/pedi.12138-BIB0010|pedi12138-cit-0010","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1200\/JCO.2001.19.13.3163","article-title":"Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study","volume":"19","author":"Mertens","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/pedi.12138-BIB0011|pedi12138-cit-0011","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1182\/blood-2010-09-304899","article-title":"Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia","volume":"117","author":"Oudin","year":"2011","journal-title":"Blood"},{"key":"10.1111\/pedi.12138-BIB0012|pedi12138-cit-0012","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MPH.0b013e3181dccc0b","article-title":"Impaired glucose tolerance and insulin resistance in survivors of childhood acute lymphoblastic leukemia: prevalence and risk factors","volume":"32","author":"Surapolchai","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1111\/pedi.12138-BIB0013|pedi12138-cit-0013","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(81)80955-9","article-title":"Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone","volume":"99","author":"Pui","year":"1981","journal-title":"J Pediatr"},{"key":"10.1111\/pedi.12138-BIB0014|pedi12138-cit-0014","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/pbc.20320","article-title":"Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia","volume":"45","author":"Baillargeon","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl. 1","key":"10.1111\/pedi.12138-BIB0015|pedi12138-cit-0015","first-page":"S43","article-title":"American Diabetes Association. Diagnosis and classification of diabetes mellitus","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12138-BIB0016|pedi12138-cit-0016","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/ijo.2008.51","article-title":"Waist-to-height ratio: a simple option for determining excess central adiposity in young people","volume":"32","author":"Garnett","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1111\/pedi.12138-BIB0017|pedi12138-cit-0017","first-page":"76","article-title":"WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length\/height, weight and age","volume":"450","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1111\/pedi.12138-BIB0018|pedi12138-cit-0018","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12138-BIB0019|pedi12138-cit-0019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/eje.0.1500097","article-title":"Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies","volume":"150","author":"Ahren","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/pedi.12138-BIB0020|pedi12138-cit-0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1464-5491.1994.tb00273.x","article-title":"Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion","volume":"11","author":"Phillips","year":"1994","journal-title":"Diabet Med"},{"key":"10.1111\/pedi.12138-BIB0021|pedi12138-cit-0021","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","article-title":"The metabolic syndrome in children and adolescents - an IDF consensus report","volume":"8","author":"Zimmet","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/pedi.12138-BIB0022|pedi12138-cit-0022","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cncr.22777","article-title":"Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality","volume":"110","author":"Ali","year":"2007","journal-title":"Cancer"},{"key":"10.1111\/pedi.12138-BIB0023|pedi12138-cit-0023","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/cncr.20071","article-title":"Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone\/methotrexate-cytarabine regimen","volume":"100","author":"Weiser","year":"2004","journal-title":"Cancer"},{"key":"10.1111\/pedi.12138-BIB0024|pedi12138-cit-0024","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(03)15264-6","article-title":"Persistence of impaired pancreatic beta-cell function in children treated for acute lymphoblastic leukaemia","volume":"363","author":"Mohn","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/pedi.12138-BIB0025|pedi12138-cit-0025","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ijo.2009.278","article-title":"Waist-to-height ratios in relation to BMI z-scores in three ethnic groups from a representative sample of New Zealand children aged 5-14 years","volume":"34","author":"Goulding","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1111\/pedi.12138-BIB0026|pedi12138-cit-0026","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.ijo.0801401","article-title":"Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index","volume":"24","author":"Savva","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1111\/pedi.12138-BIB0027|pedi12138-cit-0027","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3945\/ajcn.2010.29317","article-title":"Body mass index and waist circumference cutoffs to define obesity in indigenous New Zealanders","volume":"92","author":"Taylor","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/pedi.12138-BIB0028|pedi12138-cit-0028","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/oby.2010.217","article-title":"Predictive ability of waist-to-height in relation to adiposity in children is not improved with age and sex-specific values","volume":"19","author":"Taylor","year":"2011","journal-title":"Obesity (Silver Spring)"}],"container-title":["Pediatric Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpedi.12138","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/pedi.12138\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:07:28Z","timestamp":1671800848000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pedi.12138"}},"subtitle":["MID during ALL treatment and metabolic risk"],"short-title":[],"issued":{"date-parts":[[2014,3,28]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1111\/pedi.12138","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727455049.793530147","asserted-by":"object"}]},"ISSN":["1399-543X"],"issn-type":[{"value":"1399-543X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,28]]}}}